Offer - Urjas Oil for just ₹ 1
Triglimiprex is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Diabetes. Triglimiprex also has some secondary and off-label uses. These are listed below.
The optimal dosage of Triglimiprex is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Triglimiprex are Nausea or vomiting, Diarrhoea, Headache. While these are the most often observed Triglimiprex side effects, there are can be others also. These have been listed below. Such side effects of Triglimiprex normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that Triglimiprex has a Unknown effect for pregnant women and Safe effect on lactating mothers. It is important to know if Triglimiprex has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Triglimiprex related warnings section.
Triglimiprex is not recommended if you suffer from certain medical conditions as it can have adverse effects. Liver Disease, Kidney Disease are examples of such conditions.
Drug reaction of Triglimiprex with other medicines has been reported. A complete list of these interactions is given below.
You should also be aware that Triglimiprex is not safe while driving, and is not addiction.
Triglimiprex is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Triglimiprex safe for pregnant women?
It is not known what effect Triglimiprex will have on pregnant women, because no research work has been carried out on this till date.
Is the use of Triglimiprex safe during breastfeeding?
Triglimiprex does not show any harmful effects in lactating women.
What is the effect of Triglimiprex on the Kidneys?
There can be some harmful effects on your kidneys after taking Triglimiprex. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Triglimiprex on the Liver?
Triglimiprex can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Triglimiprex on the Heart?
Triglimiprex is rarely harmful for the heart.
Triglimiprex should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Triglimiprex unless your doctor advises you to do so -
Is this Triglimiprex habit forming or addictive?
Forming a habit of Triglimiprex has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Triglimiprex as you may feel sleepy.
Is it safe?
Yes, but consume Triglimiprex only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Triglimiprex in mental disorders is not effective.
Interaction between Food and Triglimiprex
There isn't any research available on the side effects of taking Triglimiprex with food.
Interaction between Alcohol and Triglimiprex
Information about the interaction of Triglimiprex and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Actos (pioglitazone hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 276-277
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1032-1033